vs
Krystal Biotech, Inc.（KRYS）与ROGERS CORP（ROG）财务数据对比。点击上方公司名可切换其他公司
ROGERS CORP的季度营收约是Krystal Biotech, Inc.的1.9倍（$200.5M vs $107.1M），Krystal Biotech, Inc.净利率更高（48.0% vs 2.2%，领先45.7%），Krystal Biotech, Inc.同比增速更快（17.5% vs 5.2%），Krystal Biotech, Inc.自由现金流更多（$75.4M vs $1.1M），过去两年Krystal Biotech, Inc.的营收复合增速更高（53.8% vs -3.3%）
Krystal Biotech是一家处于临床阶段的生物技术企业，专注于研发和商业化针对罕见重症皮肤病的新型基因疗法，主要面向北美和欧洲市场，服务缺乏有效常规治疗方案的单基因皮肤病患者。
罗杰斯公司是一家专注于特种工程材料研发生产的企业，总部位于美国亚利桑那州钱德勒市，其产品广泛应用于先进电子、移动通信、清洁能源、航空航天等多个高科技领域，为全球客户提供高性能材料解决方案。
KRYS vs ROG — 直观对比
营收规模更大
ROG
是对方的1.9倍
$107.1M
营收增速更快
KRYS
高出12.3%
5.2%
净利率更高
KRYS
高出45.7%
2.2%
自由现金流更多
KRYS
多$74.3M
$1.1M
两年增速更快
KRYS
近两年复合增速
-3.3%
损益表 — Q4 FY2025 vs Q1 FY2026
| 指标 | | |
|---|---|---|
| 营收 | $107.1M | $200.5M |
| 净利润 | $51.4M | $4.5M |
| 毛利率 | — | 32.2% |
| 营业利润率 | 41.5% | — |
| 净利率 | 48.0% | 2.2% |
| 营收同比 | 17.5% | 5.2% |
| 净利润同比 | 13.0% | 421.4% |
| 每股收益（稀释后） | $1.69 | $0.25 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收KRYSROG
| Q1 26 | — | $200.5M | ||
| Q4 25 | $107.1M | $201.5M | ||
| Q3 25 | $97.8M | $216.0M | ||
| Q2 25 | $96.0M | $202.8M | ||
| Q1 25 | $88.2M | $190.5M | ||
| Q4 24 | $91.1M | $192.2M | ||
| Q3 24 | $83.8M | $210.3M | ||
| Q2 24 | $70.3M | $214.2M |
净利润KRYSROG
| Q1 26 | — | $4.5M | ||
| Q4 25 | $51.4M | $4.6M | ||
| Q3 25 | $79.4M | $8.6M | ||
| Q2 25 | $38.3M | $-73.6M | ||
| Q1 25 | $35.7M | $-1.4M | ||
| Q4 24 | $45.5M | $-500.0K | ||
| Q3 24 | $27.2M | $10.7M | ||
| Q2 24 | $15.6M | $8.1M |
毛利率KRYSROG
| Q1 26 | — | 32.2% | ||
| Q4 25 | — | 31.5% | ||
| Q3 25 | — | 33.5% | ||
| Q2 25 | — | 31.6% | ||
| Q1 25 | — | 29.9% | ||
| Q4 24 | — | 32.1% | ||
| Q3 24 | — | 35.2% | ||
| Q2 24 | — | 34.1% |
营业利润率KRYSROG
| Q1 26 | — | — | ||
| Q4 25 | 41.5% | 3.5% | ||
| Q3 25 | 42.3% | 7.3% | ||
| Q2 25 | 40.9% | -33.3% | ||
| Q1 25 | 41.0% | -0.2% | ||
| Q4 24 | 45.4% | -6.6% | ||
| Q3 24 | 26.8% | 6.9% | ||
| Q2 24 | 12.2% | 5.3% |
净利率KRYSROG
| Q1 26 | — | 2.2% | ||
| Q4 25 | 48.0% | 2.3% | ||
| Q3 25 | 81.2% | 4.0% | ||
| Q2 25 | 39.9% | -36.3% | ||
| Q1 25 | 40.5% | -0.7% | ||
| Q4 24 | 49.9% | -0.3% | ||
| Q3 24 | 32.4% | 5.1% | ||
| Q2 24 | 22.2% | 3.8% |
每股收益（稀释后）KRYSROG
| Q1 26 | — | $0.25 | ||
| Q4 25 | $1.69 | $0.20 | ||
| Q3 25 | $2.66 | $0.48 | ||
| Q2 25 | $1.29 | $-4.00 | ||
| Q1 25 | $1.20 | $-0.08 | ||
| Q4 24 | $1.53 | $-0.04 | ||
| Q3 24 | $0.91 | $0.58 | ||
| Q2 24 | $0.53 | $0.44 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $496.3M | $195.8M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $1.2B | $1.2B |
| 总资产 | $1.3B | $1.4B |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资KRYSROG
| Q1 26 | — | $195.8M | ||
| Q4 25 | $496.3M | $197.0M | ||
| Q3 25 | $392.6M | $167.8M | ||
| Q2 25 | $353.8M | $157.2M | ||
| Q1 25 | $308.8M | $175.6M | ||
| Q4 24 | $344.9M | $159.8M | ||
| Q3 24 | $374.0M | $146.4M | ||
| Q2 24 | $345.8M | $119.9M |
股东权益KRYSROG
| Q1 26 | — | $1.2B | ||
| Q4 25 | $1.2B | $1.2B | ||
| Q3 25 | $1.1B | $1.2B | ||
| Q2 25 | $1.0B | $1.2B | ||
| Q1 25 | $984.7M | $1.3B | ||
| Q4 24 | $946.4M | $1.3B | ||
| Q3 24 | $885.8M | $1.3B | ||
| Q2 24 | $838.9M | $1.3B |
总资产KRYSROG
| Q1 26 | — | $1.4B | ||
| Q4 25 | $1.3B | $1.4B | ||
| Q3 25 | $1.2B | $1.4B | ||
| Q2 25 | $1.1B | $1.5B | ||
| Q1 25 | $1.1B | $1.5B | ||
| Q4 24 | $1.1B | $1.5B | ||
| Q3 24 | $982.3M | $1.5B | ||
| Q2 24 | $917.7M | $1.5B |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $77.5M | $5.8M |
| 自由现金流经营现金流 - 资本支出 | $75.4M | $1.1M |
| 自由现金流率自由现金流/营收 | 70.4% | 0.5% |
| 资本支出强度资本支出/营收 | 2.0% | 2.3% |
| 现金转化率经营现金流/净利润 | 1.51× | 1.29× |
| 过去12个月自由现金流最近4个季度 | $188.9M | $70.1M |
8季度趋势，按日历期对齐
经营现金流KRYSROG
| Q1 26 | — | $5.8M | ||
| Q4 25 | $77.5M | $46.9M | ||
| Q3 25 | $39.7M | $28.9M | ||
| Q2 25 | $52.7M | $13.7M | ||
| Q1 25 | $31.0M | $11.7M | ||
| Q4 24 | $52.8M | $33.7M | ||
| Q3 24 | $58.9M | $42.4M | ||
| Q2 24 | $-4.2M | $22.9M |
自由现金流KRYSROG
| Q1 26 | — | $1.1M | ||
| Q4 25 | $75.4M | $42.2M | ||
| Q3 25 | $38.0M | $21.2M | ||
| Q2 25 | $50.8M | $5.6M | ||
| Q1 25 | $24.8M | $2.1M | ||
| Q4 24 | $52.0M | $18.3M | ||
| Q3 24 | $57.8M | $25.2M | ||
| Q2 24 | $-5.3M | $8.8M |
自由现金流率KRYSROG
| Q1 26 | — | 0.5% | ||
| Q4 25 | 70.4% | 20.9% | ||
| Q3 25 | 38.8% | 9.8% | ||
| Q2 25 | 52.9% | 2.8% | ||
| Q1 25 | 28.1% | 1.1% | ||
| Q4 24 | 57.1% | 9.5% | ||
| Q3 24 | 69.0% | 12.0% | ||
| Q2 24 | -7.5% | 4.1% |
资本支出强度KRYSROG
| Q1 26 | — | 2.3% | ||
| Q4 25 | 2.0% | 2.3% | ||
| Q3 25 | 1.7% | 3.6% | ||
| Q2 25 | 2.0% | 4.0% | ||
| Q1 25 | 7.0% | 5.0% | ||
| Q4 24 | 0.9% | 8.0% | ||
| Q3 24 | 1.2% | 8.2% | ||
| Q2 24 | 1.6% | 6.6% |
现金转化率KRYSROG
| Q1 26 | — | 1.29× | ||
| Q4 25 | 1.51× | 10.20× | ||
| Q3 25 | 0.50× | 3.36× | ||
| Q2 25 | 1.38× | — | ||
| Q1 25 | 0.87× | — | ||
| Q4 24 | 1.16× | — | ||
| Q3 24 | 2.17× | 3.96× | ||
| Q2 24 | -0.27× | 2.83× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
